SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001213900-21-018272
Filing Date
2021-03-29
Accepted
2021-03-29 16:01:40
Documents
42
Period of Report
2020-12-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT f10k2020_geminitherape.htm 10-K 896409
2 CERTIFICATION f10k2020ex31-1_gemini.htm EX-31.1 10275
3 CERTIFICATION f10k2020ex31-2_gemini.htm EX-31.2 10098
4 CERTIFICATION f10k2020ex32-1_gemini.htm EX-32.1 3999
5 CERTIFICATION f10k2020ex32-2_gemini.htm EX-32.2 3835
  Complete submission text file 0001213900-21-018272.txt   2645097

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE gmtx-20201231.xml EX-101.INS 173025
7 XBRL SCHEMA FILE gmtx-20201231.xsd EX-101.SCH 31791
8 XBRL CALCULATION FILE gmtx-20201231_cal.xml EX-101.CAL 23340
9 XBRL DEFINITION FILE gmtx-20201231_def.xml EX-101.DEF 151215
10 XBRL LABEL FILE gmtx-20201231_lab.xml EX-101.LAB 274354
11 XBRL PRESENTATION FILE gmtx-20201231_pre.xml EX-101.PRE 157511
Mailing Address 300 ONE KENDALL SQUARE, 3RD FLOOR CAMBRIDGE MA 02139
Business Address 300 ONE KENDALL SQUARE, 3RD FLOOR CAMBRIDGE MA 02139 (617) 401-4400
Gemini Therapeutics, Inc. /DE (Filer) CIK: 0001816736 (see all company filings)

IRS No.: 851613057 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-39438 | Film No.: 21781684
SIC: 2834 Pharmaceutical Preparations